Clinical trials
Enrolling by invitation Cardiomyopathies trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 1 |
| Lexeo Therapeutics | 1 |
| Peerbridge Health, Inc | 1 |
| The Cooper Health System | 1 |
| Truway Health, Inc. | 1 |
| University of California, Los Angeles | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathies | 6 |
| Heart Failure | 3 |
| Arrhythmias, Cardiac | 2 |
| Death, Sudden, Cardiac | 2 |
| Acute Kidney Injury | 1 |
| Amyloidosis | 1 |
| Aortic Diseases | 1 |
| Arrhythmogenic Right Ventricular Dysplasia | 1 |
| Atrial Fibrillation | 1 |
| Atrial Remodeling | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.